Pharmafile Logo

Value-Based Cancer Care

- PMLiVE

GSK and Medicago’s COVID-19 vaccine shows promising antibody responses in phase 2

Neutralising antibody responses in vaccinated participants were about ten times higher than those seen in a panel of sera from recovering COVID-19 patients

- PMLiVE

US Supreme Court rebuffs Sandoz’s Enbrel biosimilar patent case

Amgen will retain market exclusivity on blockbuster arthritis drug until 2029

- PMLiVE

Detailed results for Regeneron’s antibody cocktail continue to show benefit in high-risk COVID-19 outpatients

Treatment shortened symptom duration and reduced viral load in non-hospitalised patients with COVID-19

- PMLiVE

Launch engagement

How the pandemic is forcing a fresh focus on the human touch and fresh thinking about engagement

- PMLiVE

Mastering commercial launch excellence in a human-centric, hybrid world

By Mike Ballas, Madelaine Allen and Dan Masquelier

- PMLiVE

FDA approves Apellis’ Empaveli for rare blood disease

PEGASUS study results show Empaveli is better than Soliris at improving haemoglobin levels

- PMLiVE

BMS builds case for cardiovascular drug mavacamten with new analysis

BMS initially picked up mavacamten as part of its $13.1bn acquisition of MyoKardia last year

- PMLiVE

Sanofi, GSK’s COVID-19 vaccine generates strong immune responses across all age groups

Sanofi/GSK delayed their COVID-19 vaccine programme in December 2020 after the vaccine candidate induced low immune responses in older adults

- PMLiVE

Avenir Global moves four UK agencies into new office space in London

AXON, Cherry, Hanover and Madano will now be based in London’s Bankside area

- PMLiVE

WebMD acquires UK-based healthcare publisher MGP

MGP will continue to operate as an independent subsidiary following acquisition completion

Research Partnership’s MedTech Division appoints two Directors

Chris Carles has joined as a Director in our Philadelphia office and Andrew Way as a Research Director in our UK office.

Inizio

- PMLiVE

VMLY&Rx launches new payer agency in the US

VMLY&Rx Payer will be helmed by healthcare comms industry veteran HeeSun Yu

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links